BCAAs in Concussion 3.0
NCT07670195
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Concussion (Diagnosis)
- MTBI - Mild Traumatic Brain Injury
- Concussion, Brain
- Concussion
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 11 to 23 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Akiva Cohen
- Last updated on ClinicalTrials.gov
- September 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 1
- Children's Hospital of Philadelphia · Havertown, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.